Related Experiment Video
Updated: May 19, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Impaired cortical actin dynamics via lanosterol-dependent HMG-CoA reductase downregulation mediates IFN-α-induced
Rema Naskar1, Liu Ye1, Sanu Karan2
1Laboratory of Immunology and Immunopharmacology, College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
Abstract:
Independent studies have reported that interferon-β induces CYP51A1 downregulation leading to lanosterol (LAN) accumulation; that LAN triggers HMG-CoA reductase (HMGCR) downregulation; and that statin-mediated HMGCR inhibition suppresses mast cell activation. Building on these findings, we investigated whether the known mast cell-stabilizing effect of IFN-α/β is driven by this LAN-induced HMGCR downregulation. In bone marrow-derived mast cells (BMMCs), interferon-α (IFN-α) indeed induced HMGCR downregulation via both ubiquitin-mediated protein degradation and transcriptional suppression, alongside CYP51A1 downregulation and LAN accumulation. Cotreatment with terbinafine, a squalene epoxidase inhibitor used to prevent LAN synthesis, restored HMGCR expression to control levels and resulted in full recovery of bone marrow-derived mast cell function. Cotreatment with specific intermediates of the mevalonate (MVA) pathway (i.e., mevalonolactone, farnesol, and geranylgeraniol) also counteracted the mast cell-stabilizing effect of IFN-α, without altering the HMGCR and CYP51A1 expression levels. These results indicate that attenuating the MVA pathway via LAN-induced HMGCR downregulation is directly responsible for the observed IFN-α-induced mast cell stabilization. Notably, IFN-α compromised the cortical actin dynamics necessary for high-affinity IgE receptor-induced LAT-PLC-γ1 signalosome assembly. These dynamics and signalosome assembly were also fully restored by cotreatment with terbinafine or the MVA pathway intermediates, as well as by the F-actin-destabilizing agent cytochalasin D. These findings were validated in vivo using a mouse model of passive cutaneous anaphylaxis and ex vivo mast cell degranulation assays. Together, our study reveals a previously unrecognized mechanism of immune regulation in which IFN-α stabilizes mast cells by impairing cortical actin dynamics through the CYP51A1-LAN-HMGCR axis.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Intracellular Signaling Affects Focal Adhesions
Some...